Global Information
회사소개 | 문의 | 비교리스트

세계의 치료 백신 시장 : 종류별, 제품별, 기술별, 전달 메커니즘별, 최종사용자별, 지역별 예측과 기회

Global Therapeutic Vaccines Market By Type, By Product, By Technology, By Delivery Mechanism, By End User, By Region, Forecast & Opportunities, 2025

리서치사 TechSci Research
발행일 2020년 05월 상품 코드 934725
페이지 정보 영문 114 Pages
가격
US $ 4,450 ₩ 5,119,000 Unprintable PDF and Excel (Single User License)
US $ 5,450 ₩ 6,270,000 PDF and Excel (Multi-User License)
US $ 9,450 ₩ 10,872,000 PDF and Excel (Custom Research License)

TechSci Research 보고서는 10% Customization 서비스가 포함되어 있습니다. 보고서에 포함돼 있지 않은 리서치 데이터와 시장 동향을 추가적으로 요청할 수 있습니다. 자세한 사항은 문의하여 주시기 바랍니다.



세계의 치료 백신 시장 : 종류별, 제품별, 기술별, 전달 메커니즘별, 최종사용자별, 지역별 예측과 기회 Global Therapeutic Vaccines Market By Type, By Product, By Technology, By Delivery Mechanism, By End User, By Region, Forecast & Opportunities, 2025
발행일 : 2020년 05월 페이지 정보 : 영문 114 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

치료 백신에는 중독 백신, 자가면역질환 백신, 신경질환 백신, 암백신, 감염증 백신 등이 있습니다. 소비자 수요에 대응하기 위해 대형 제약회사는 향후 120개 종류에 달하는 새로운 백신을 세계 각지 시장에 투입할 것으로 보이며, 치명적 질환과 만성 질환의 유병률에 관한 의식이 높아지는 가운데 시장은 자가면역질환 백신을 중심으로 향후 두 자리수대의 CAGR로 성장할 것으로 예상됩니다.

세계의 치료 백신(Therapeutic Vaccines) 시장을 조사했으며, 신종 코로나바이러스 감염증(COVID-19)이 시장에 미치는 영향, 각 지역 시장 전망, 시장 역학과 동향, 경쟁 상황과 주요 기업 개요 등의 정보와 함께 전략적 제안도 제시하고 있습니다.

목차

제1장 제품 개요

제2장 조사 방법

제3장 신종 코로나바이러스 감염증(COVID-19)이 시장에 미치는 영향

제4장 고객의 소리

제5장 주요 요약

제6장 세계 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 종류별(항원 백신, 수지상세포 백신, DNA 백신, 종양세포 백신)
    • 제품별(중독 백신, 자가면역질환 백신, 신경질환 백신, 암백신, 감염증 백신, 기타)
    • 기술별(자가 백신, 동종이계 백신)
    • 전달 메커니즘별(경비 투여, 일렉트로포레이션)
    • 최종사용자별(사립 병원, 공립 병원, 전문 클리닉)
    • 기업별(2019년)
    • 지역별
  • 시장 매력 지수

제7장 아시아태평양 시장 전망

  • 시장 규모와 예측
    • 금액 기준
  • 시장 점유율과 예측
    • 종류별
    • 기술별
    • 최종사용자별
    • 국가별
  • 아시아태평양 : 국가별 분석
    • 중국
    • 인도
    • 일본
    • 한국
    • 싱가포르
    • 호주

제8장 유럽 시장 전망

  • 시장 규모와 예측
    • 금액 기준
  • 시장 점유율과 예측
    • 종류별
    • 기술별
    • 최종사용자별
    • 국가별
  • 유럽 : 국가별 분석
    • 프랑스
    • 독일
    • 영국
    • 이탈리아
    • 스페인

제9장 북미 시장 전망

  • 시장 규모와 예측
    • 금액 기준
  • 시장 점유율과 예측
    • 종류별
    • 기술별
    • 최종사용자별
    • 국가별
  • 북미 : 국가별 분석
    • 미국
    • 멕시코
    • 캐나다

제10장 남미 시장 전망

  • 시장 규모와 예측
    • 금액 기준
  • 시장 점유율과 예측
    • 종류별
    • 기술별
    • 최종사용자별
    • 국가별
  • 남미 : 국가별 분석
    • 브라질
    • 아르헨티나
    • 콜롬비아

제11장 중동 및 아프리카 시장 전망

  • 시장 규모와 예측
    • 금액 기준
  • 시장 점유율과 예측
    • 종류별
    • 기술별
    • 최종사용자별
    • 국가별
  • 중동 및 아프리카 : 국가별 분석
    • 남아프리카공화국
    • 사우디아라비아
    • UAE

제12장 시장 역학

  • 성장 촉진요인
  • 과제
  • Porter's Five Forces 분석으로 밝혀지는 과제

제13장 시장 동향과 발전

제14장 경쟁 상황

  • 경쟁 상황 전망
  • 주요 기업 개요
    • Sanofi Pasteur SA de CV
    • Intellect Neurosciences Inc
    • Agenus Inc
    • Celtic Pharma Holdings Advisors LLC
    • Novartis AG
    • Bavarian Nordic A/S
    • Transgene SA
    • Argos Therapeutics Inc
    • Celldex Therapeutics Inc
    • CureVac GmbH

제15장 전략적 제안

제16장 면책사항

KSM 20.05.18

Global therapeutic vaccines market is expected to grow at a double digit CAGR during the forecast period on account of increasing awareness in the population about prevalence of fatal and chronic diseases. Moreover, on account of increasing demand from consumers, 120 new vaccines are also anticipated to be introduced globally by different multinational companies, thereby driving the market. Since vaccines are prepared for a special type of disease, it can be said that this market is a demand-based market.

Global therapeutic vaccines market is segmented on the basis of type, product, technology, delivery mechanism, end user, company and region. Type segment is further segregated into addiction vaccines, auto immune disease vaccines, neurological disease vaccines, cancer vaccines, infectious disease vaccine and others. Auto immune disease vaccines held the largest market share in 2019 as auto immune diseases are responsible for majority of deaths all over the world.

In terms of regional analysis, Asia-Pacific is anticipated to grow at the highest rate until 2025 owing to increasing patient awareness and improving healthcare infrastructure. Moreover, favorable regulations and initiatives taken by the government in the economies present in the region are positively impacting the growth of the market.

Leading players in the global therapeutic vaccines market include Sanofi Pasteur SA de CV, Intellect Neurosciences Inc, Agenus Inc, Celtic Pharma Holdings Advisors LLC, Novartis AG, Bavarian Nordic A/S, Transgene SA, Argos Therapeutics Inc, Celldex Therapeutics Inc, CureVac GmbH, etc. The companies operating in the global therapeutic vaccines market are adoption inorganic and organic growth strategies to increase their share in the market.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

XXXXXObjective of the StudyYYYYY:

  • To analyze and forecast the market size of global therapeutic vaccines market.
  • To classify and forecast global therapeutic vaccines market based on type, product, technology, delivery mechanism, end user, company and region.
  • To identify drivers and challenges for global therapeutic vaccines market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global therapeutic vaccines market.
  • To conduct pricing analysis for global therapeutic vaccines market.
  • To identify and analyze the profile of leading players operating in global therapeutic vaccines market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global therapeutic vaccines market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

XXXXXKey Target AudienceYYYYY:

  • Therapeutic vaccines manufacturers, suppliers, distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to therapeutic vaccine
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

XXXXXReport ScopeYYYYY:

In this report, global therapeutic vaccines market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Type:

Antigen Vaccine

Dendritic Cell Vaccine

DNA Vaccines

Tumor Cell Vaccine

  • Market, By Product:

Addiction Vaccines

Auto Immune Disease Vaccines

Neurological Disease Vaccines

Cancer Vaccines

Infectious Disease Vaccine

Others

  • Market, By Technology:

Autologous Vaccines

Allogeneic Vaccines

  • Market, By Delivery Mechanism:

Nasal

Electroporation

  • Market, By End User:

Private Hospitals

Government Hospitals

Specialty Clinics

  • Market, By Region:

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Singapore
  • Australia

Europe

  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain

North America

  • United States
  • Mexico
  • Canada

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

XXXXXCompetitive LandscapeYYYYY

Company Profiles: Detailed analysis of the major companies present in global therapeutic vaccines market.

XXXXXAvailable CustomizationsYYYYY:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID 19 on Global Therapeutic Vaccines Market

4. Voice of Customers

5. Executive Summary

6. Global Therapeutic Vaccines Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Antigen Vaccine, Dendritic Cell Vaccine, DNA Vaccines, Tumor cell vaccine)
    • 6.2.2. By Product (Addiction Vaccines, Auto Immune Disease Vaccines, Neurological Disease Vaccines, Cancer Vaccines, Infectious Disease Vaccine, Others)
    • 6.2.3. By Technology (Autologous Vaccines, Allogeneic Vaccines)
    • 6.2.4. By Delivery Mechanism (Nasal, Electroporation)
    • 6.2.5. By End User (Private Hospitals, Government Hospitals, Specialty Clinics)
    • 6.2.6. By Company (2019)
    • 6.2.7. By Region
  • 6.3. Market Attractiveness Index

7. Asia-Pacific Therapeutic Vaccines Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Technology
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Asia-Pacific: Country Analysis
    • 7.3.1. China Therapeutic Vaccines Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By End User
    • 7.3.2. India Therapeutic Vaccines Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By End User
    • 7.3.3. Japan Therapeutic Vaccines Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By End User
    • 7.3.4. South Korea Therapeutic Vaccines Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By End User
    • 7.3.5. Singapore Therapeutic Vaccines Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By End User
    • 7.3.6. Australia Therapeutic Vaccines Market Outlook
      • 7.3.6.1. Market Size & Forecast
        • 7.3.6.1.1. By Value
      • 7.3.6.2. Market Share & Forecast
        • 7.3.6.2.1. By Product Type
        • 7.3.6.2.2. By Technology
        • 7.3.6.2.3. By End User

8. Europe Therapeutic Vaccines Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Technology
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Therapeutic Vaccines Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By End User
    • 8.3.2. Germany Therapeutic Vaccines Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By End User
    • 8.3.3. United Kingdom Therapeutic Vaccines Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By End User
    • 8.3.4. Italy Therapeutic Vaccines Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By End User
    • 8.3.5. Spain Therapeutic Vaccines Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By End User

9. North America Therapeutic Vaccines Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Technology
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Therapeutic Vaccines Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By End User
    • 9.3.2. Mexico Therapeutic Vaccines Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By End User
    • 9.3.3. Canada Therapeutic Vaccines Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By End User

10. South America Therapeutic Vaccines Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Technology
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Therapeutic Vaccines Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By End User
    • 10.3.2. Argentina Therapeutic Vaccines Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By End User
    • 10.3.3. Colombia Therapeutic Vaccines Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By End User

11. Middle East and Africa Therapeutic Vaccines Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product Type
    • 11.2.2. By Technology
    • 11.2.3. By End User
    • 11.2.4. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Therapeutic Vaccines Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product Type
        • 11.3.1.2.2. By Technology
        • 11.3.1.2.3. By End User
    • 11.3.2. Saudi Arabia Therapeutic Vaccines Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product Type
        • 11.3.2.2.2. By Technology
        • 11.3.2.2.3. By End User
    • 11.3.3. UAE Therapeutic Vaccines Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product Type
        • 11.3.3.2.2. By Technology
        • 11.3.3.2.3. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges
  • 12.3. Porter's Five forces challenge

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Players Profiled (Leading Companies)
    • 14.2.1. Sanofi Pasteur SA de CV
    • 14.2.2. Intellect Neurosciences Inc
    • 14.2.3. Agenus Inc
    • 14.2.4. Celtic Pharma Holdings Advisors LLC
    • 14.2.5. Novartis AG
    • 14.2.6. Bavarian Nordic A/S
    • 14.2.7. Transgene SA
    • 14.2.8. Argos Therapeutics Inc
    • 14.2.9. Celldex Therapeutics Inc
    • 14.2.10. CureVac GmbH

15. Strategic Recommendations

16. About Us & Disclaimer

Back to Top
전화 문의
F A Q